首页> 外国专利> 5-AMINO-4-HYDROXY-7- (IMIDAZO1,2-ATPYRIDINE-6-YLMETHYL) -8-METHYLNONAMID DERIVATIVES AND RELATED COMPOUNDS AS RENININHIBITORS FOR THE TREATMENT OF HYPERTENSIVE HUMIDITY

5-AMINO-4-HYDROXY-7- (IMIDAZO1,2-ATPYRIDINE-6-YLMETHYL) -8-METHYLNONAMID DERIVATIVES AND RELATED COMPOUNDS AS RENININHIBITORS FOR THE TREATMENT OF HYPERTENSIVE HUMIDITY

机译:5-胺基-4-羟基-7-(咪唑基1,2-ATP吡啶-6-亚甲基)-8-甲基壬酰胺衍生物和相关化合物作为抗高血压药治疗高血压

摘要

Compounds of the general formula (I) or its salt or a compound in which one or more atoms are replaced by their stable, nonradio-active isotopes, in particular its pharmaceutically acceptable sa in which X is CH2; R is a mono- to tetra-substituted, mono- or bicyclic, unsaturated heterocyclic radical having 1 to 4 nitrogen atoms, R2 is C1-6alkyl or C3-6cycloalkyl; R3 is independently of one another H, C1-6alkyl, C1-6alkoxycarbonyl or C1-6alkanoyl; R4 is C2-6alkenyl, C1-6alkyl, unsubstituted or substituted aryl-C1-6alkyl or C3-8cycloalkyl; R5 is -Lm-R6; L is C1-6alkylene which is optionally substituted by 1-4 halogen, or a linker: formula (II) n=0, 1 or 2; m=0 or 1; R6 is a radical composed of 2 cyclic systems selected from bicyclo[x.y.z]alkyl, spiro[o.p]alkyl, mono- or bioxabicyclo[x.y.z]alkyl or mono- or bioxaspiro[o.p]alkyl, all of which may be substituted by 1-3 substituents selected from C1-6alkyl, C1-6alkoxy, cyano, halogen, C1-6alkoxy-C1-6alkyl, hydroxy-C1-6alkyl or dialkylamino, or if m=0: is also saturated C3-8heterocyclyl which comprises 1-2 oxygen atoms, substituted by 1-3 substituents selected from C1-6alkyl, C1-6alkoxy, cyano, halogen, C1-6alkoxy-C1-6alkyl, hydroxy-C1-6alkyl or dialkylamino, or if m=1: is also saturated C3-8heterocyclyl which comprises 1-2 oxygen atoms, optionally substituted by 1-3 substituents selected from C1-6alkyl, C1-6alkoxy, cyano, halogen, C1-6-alkoxy-C1-6alkyl, hydroxy-C1-6alkyl or dialkylamino; have renin-inhibiting properties and can be used as medicines for the treatment of hypertension.
机译:通式(I)的化合物或其盐或一个或多个原子被其稳定的非放射性同位素取代的化合物,特别是其药学上可接受的盐;其中X是CH 2; R为具有1-4个氮原子的单至四取代的单环或双环不饱和杂环基,R 2为C 1-6烷基或C 3-6环烷基; R 3彼此独立地为H,C 1-6烷基,C 1-6烷氧基羰基或C 1-6烷酰基; R4为C2-6链烯基,C1-6烷基,未取代或取代的芳基-C1-6烷基或C3-8环烷基; R5是-Lm-R6; L为任选被1-4个卤素或连接基取代的C 1-6亚烷基;或连接基:式(II),n = 0、1或2; m = 0或1; R 6是由2个选自双环[xyz]烷基,螺环烷基,单或生物xabicyclo [xyz]烷基或单-或生物xaspiro [op]烷基的环状系统组成的基团,所有这些都可以被1-取代3个选自C 1-6烷基,C 1-6烷氧基,氰基,卤素,C 1-6烷氧基-C 1-6烷基,羟基-C 1-6烷基或二烷基氨基的取代基,或者如果m = 0:也是包含1-2个氧的饱和C 3-8杂环基原子,被1-3个选自C1-6烷基,C1-6烷氧基,氰基,卤素,C1-6烷氧基-C1-6烷基,羟基-C1-6烷基或二烷基氨基的取代基取代,或者如果m = 1:也是饱和的C3-8杂环基包含1-2个氧原子,任选地被1-3个选自C 1-6烷基,C 1-6烷氧基,氰基,卤素,C 1-6-烷氧基-C 1-6烷基,羟基-C 1-6烷基或二烷基氨基的取代基取代;具有抑制肾素的特性,可以用作治疗高血压的药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号